Isonipecotic acid

CAS No. 498-94-2

Isonipecotic acid( 4-Piperidinecarboxylic acid | 4-Carboxypiperidine | Hexahydroisonicotinic acid )

Catalog No. M27557 CAS No. 498-94-2

Isonipecotic acid is a heterocyclic compound. Isonipecotic acid mainly characterized as a GABAA receptor partial agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    Isonipecotic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Isonipecotic acid is a heterocyclic compound. Isonipecotic acid mainly characterized as a GABAA receptor partial agonist.
  • Description
    Isonipecotic acid is a heterocyclic compound. Isonipecotic acid mainly characterized as a GABAA receptor partial agonist.
  • In Vitro
    Isonipecotic acid inhibits [3H]GABA binding (2°C) with an IC50 of 0.33 μM.
  • In Vivo
    ——
  • Synonyms
    4-Piperidinecarboxylic acid | 4-Carboxypiperidine | Hexahydroisonicotinic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Bacterial|Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    498-94-2
  • Formula Weight
    129.159
  • Molecular Formula
    C6H11NO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 100 mg/mL (774.23 mM)
  • SMILES
    OC(=O)C1CCNCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kehai Liu, et al. Isolation and biological activities of decanal, linalool, valencene, and octanal from sweet orange oil. J Food Sci. 2012 Nov;77(11):C1156-61.
molnova catalog
related products
  • WRW4 TFA(878557-55-2...

    Selective antagonist of formyl peptide receptor 2 (FPR2) signaling. Inhibits WKYMVm binding to FPR2 (IC50 = 0.23 μM) and inhibits intracellular calcium release induced by WKYMVm, MMK 1, amyloid β42, and F peptide. Also inhibits FPR2-mediated signaling in human neutrophils; blocks chemotactic migration and superoxide generation by amyloid β42 peptide.

  • Laurocapram

    Laurocapram is a percutaneous enhancer. Upon application to the skin, laurocapram interacts with lipids in the stratum corneum and may enhance the ability of the skin to absorb a hydrophilic chemical.

  • Neoastragaloside I

    Neoastragaloside I is a natural product.